Meeder Advisory Services’s Biogen BIIB Stock Holding History

Meeder Advisory Services’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$996K	Sell	4,608 -113	-2%	-$21.6K	0.04%	306
2026 Q1	$866K	Buy	4,721 +57	+1%	+$10.5K	0.04%	302
2025 Q4	$821K	Buy	4,664 +290	+7%	+$47.4K	0.04%	309
2025 Q3	$613K	Buy	4,374 +165	+4%	+$22.3K	0.03%	351
2025 Q2	$529K	Buy	4,209 +2,599	+161%	+$324K	0.03%	364
2025 Q1	$220K	Buy	1,610 +218	+16%	+$31.2K	0.01%	526
2024 Q4	$213K	Sell	1,392 -130	-9%	-$21.9K	0.01%	526
2024 Q3	$295K	Sell	1,522 -429	-22%	-$89.8K	0.02%	441
2024 Q2	$452K	Buy	1,951 +422	+28%	+$91.7K	0.03%	339
2024 Q1	$330K	Sell	1,529 -159	-9%	-$37.2K	0.03%	337
2023 Q4	$437K	Sell	1,688 -6	-0.4%	-$1.47K	0.05%	287
2023 Q3	$435K	Sell	1,694 -417	-20%	-$112K	0.05%	284
2023 Q2	$601K	Buy	2,111 +126	+6%	+$37.5K	0.06%	254
2023 Q1	$552K	Buy	1,985 +287	+17%	+$79.4K	0.06%	259
2022 Q4	$470K	Buy	+1,698	New	+$480K	0.06%	271

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Meeder Advisory Services's BIIB Position: Q2 2026 in Review

Meeder Advisory Services reduced its Biogen (BIIB) stake by 2.4% in Q2 2026, selling an estimated $21.6K and leaving 4,608 shares worth $996K. The position accounts for 0.04% of the portfolio, ranked #306.

Meeder Advisory Services first reported a position in BIIB in Q4 2022 and has held it in 15 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Meeder Advisory Services held 4,608 shares of Biogen worth $996K as of Q2 2026.
Meeder Advisory Services sold 113 Biogen shares in Q2 2026, an estimated $21.6K.
Biogen made up 0.04% of Meeder Advisory Services's portfolio in Q2 2026, its #306 holding.
Meeder Advisory Services first reported a position in Biogen in Q4 2022 and has held it in 15 quarters since.
1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.